Reorganized PKA-AKAP associations in the failing human heart

Journal of Molecular and Cellular Cardiology

Volumn 52, Issue 2, 2012, Pages 511-518

  Aye, Thin Thin ^a,b,e   Soni, Siddarth ^a,c   van Veen, Toon A B ^c   van der Heyden, Marcel A G ^c   Cappadona, Salvatore ^a,b   Varro, Andras ^d   de Weger, Roel A ^c   de Jonge, Nicolaas ^c   Vos, Marc A ^c   Heck, Albert J R ^a,b   Scholten, Arjen ^a,b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b NETHERLANDS PROTEOMICS CENTRE   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d UNIVERSITY OF SZEGED   (Hungary)

^e UNIVERSITY OF BERGEN   (Norway)

Author keywords

AKAP; Chemical proteomics; Cyclic nucleotides; Heart failure; Label free quantitation; Novel therapeutics

Indexed keywords

A KINASE ANCHORING PROTEIN 1; A KINASE ANCHORING PROTEIN 13; A KINASE ANCHORING PROTEIN 7; A KINASE ANCHORING PROTEIN 9; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE TYPE 2 DELTA; CARDIAC MYOSIN BINDING PROTEIN C; CONNECTIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN; CYCLIC AMP DEPENDENT PROTEIN KINASE REGULATORY SUBUNIT IALPHA; CYCLIC AMP DEPENDENT PROTEIN KINASE REGULATORY SUBUNIT IIALPHA; CYCLIC GMP DEPENDENT PROTEIN KINASE; MICROTUBULE ASSOCIATED PROTEIN 2; MYOSIN BINDING PROTEIN C; PALM2 A KINASE ANCHORING PROTEIN 2; PHOSPHODIESTERASE; PHOSPHODIESTERASE 2A; PROTEIN KINASE G IALPHA; SPHKAP PROTEIN; TROPONIN C; TROPONIN I; TROPONIN T; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART FAILURE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; QRS COMPLEX; QT PROLONGATION; UPREGULATION;

A KINASE ANCHOR PROTEINS; ADULT; AGED; CYCLIC AMP-DEPENDENT PROTEIN KINASES; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; MYOFIBRILS; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; PROTEOME; SIGNAL TRANSDUCTION; YOUNG ADULT;

MAMMALIA;

EID: 82255177626     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2011.06.003     Document Type: Article

References (51)

1. Kass D.A. Message delivered: how myocytes control cAMP signaling. Circ Res 2008, 102:1002-1004.
2. Bristow M.R., Ginsburg R., Umans V., Fowler M., Minobe W., Rasmussen R., et al. Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure. Circ Res 1986, 59:297-309.
3. Anderson M.E., Higgins L.S., Schulman H. Disease mechanisms and emerging therapies: protein kinases and their inhibitors in myocardial disease. Nat Clin Pract Cardiovasc Med 2006, 3:437-445.
4. Zakhary D.R., Moravec C.S., Stewart R.W., Bond M. Protein kinase A (PKA)-dependent troponin-I phosphorylation and PKA regulatory subunits are decreased in human dilated cardiomyopathy. Circulation 1999, 99:505-510.
5. Schwinger R.H., Munch G., Bolck B., Karczewski P., Krause E.G., Erdmann E. Reduced Ca(2+)-sensitivity of SERCA 2a in failing human myocardium due to reduced serin-16 phospholamban phosphorylation. J Mol Cell Cardiol 1999, 31:479-491.
6. Fink M.A., Zakhary D.R., Mackey J.A., Desnoyer R.W., Apperson-Hansen C., Damron D.S., et al. AKAP-mediated targeting of protein kinase a regulates contractility in cardiac myocytes. Circ Res 2001, 88:291-297.
7. Zakhary D.R., Moravec C.S., Bond M. Regulation of PKA binding to AKAPs in the heart: alterations in human heart failure. Circulation 2000, 101:1459-1464.
8. Movsesian M.A. Altered cAMP-mediated signalling and its role in the pathogenesis of dilated cardiomyopathy. Cardiovasc Res 2004, 62:450-459.
9. Scott J.D., Santana L.F. A-kinase anchoring proteins: getting to the heart of the matter. Circulation 2010, 121:1264-1271.
10. Scholten A., Poh M.K., van Veen T.A., van Breukelen B., Vos M.A., Heck A.J. Analysis of the cGMP/cAMP interactome using a chemical proteomics approach in mammalian heart tissue validates sphingosine kinase type 1-interacting protein as a genuine and highly abundant AKAP. J Proteome Res 2006, 5:1435-1447.
11. Scholten A., van Veen T.A., Vos M.A., Heck A.J. Diversity of cAMP-dependent protein kinase isoforms and their anchoring proteins in mouse ventricular tissue. J Proteome Res 2007, 6:1705-1717.
12. Lygren B., Tasken K. The potential use of AKAP18delta as a drug target in heart failure patients. Expert Opin Biol Ther 2008, 8:1099-1108.
13. World Medical Association Declaration of Helsinki Recommendations guiding physicians in biomedical research involving human subjects. Cardiovasc Res 1997, 35:2-3.
14. Aye T.T., Mohammed S., van den Toorn H.W., van Veen T.A., van der Heyden M.A., Scholten A., et al. Selectivity in enrichment of cAMP-dependent protein kinase regulatory subunits type I and type II and their interactors using modified cAMP affinity resins. Mol Cell Proteomics 2009, 8:1016-1028.
15. Cox J., Mann M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol 2008, 26:1367-1372.
16. Hubner N.C., Bird A.W., Cox J., Splettstoesser B., Bandilla P., Poser I., et al. Quantitative proteomics combined with BAC TransgeneOmics reveals in vivo protein interactions. J Cell Biol 2010, 189:739-754.
17. Paoletti A.C., Parmely T.J., Tomomori-Sato C., Sato S., Zhu D., Conaway R.C., et al. Quantitative proteomic analysis of distinct mammalian Mediator complexes using normalized spectral abundance factors. Proc Natl Acad Sci USA 2006, 103:18928-18933.
18. Aye T.T., Scholten A., Taouatas N., Varro A., Van Veen T.A., Vos M.A., et al. Proteome-wide protein concentrations in the human heart. Mol Biosyst 2010, 6:1917-1927.
19. Hoch B., Meyer R., Hetzer R., Krause E.G., Karczewski P. Identification and expression of delta-isoforms of the multifunctional Ca2+/calmodulin-dependent protein kinase in failing and nonfailing human myocardium. Circ Res 1999, 84:713-721.
20. Kovanich D., van der Heyden M.A., Aye T.T., van Veen T.A., Heck A.J., Scholten A. Sphingosine kinase interacting protein is an A-kinase anchoring protein specific for type I cAMP-dependent protein kinase. Chembiochem 2010, 11:963-971.
21. Sumandea C.A., Garcia-Cazarin M.L., Bozio C.H., Sievert G.A., Balke C.W., Sumandea M.P. Cardiac troponin T, a sarcomeric AKAP, tethers protein kinase A at the myofilaments. J Biol Chem 2010, 286:530-541.
22. Fukuda N., Wu Y., Nair P., Granzier H.L. Phosphorylation of titin modulates passive stiffness of cardiac muscle in a titin isoform-dependent manner. J Gen Physiol 2005, 125:257-271.
23. Solaro R.J., Moir A.J., Perry S.V. Phosphorylation of troponin I and the inotropic effect of adrenaline in the perfused rabbit heart. Nature 1976, 262:615-617.
24. Jeacocke S.A., England P.J. Phosphorylation of a myofibrillar protein of Mr 150 000 in perfused rat heart, and the tentative indentification of this as C-protein. FEBS Lett 1980, 122:129-132.
25. Barrans J.D., Allen P.D., Stamatiou D., Dzau V.J., Liew C.C. Global gene expression profiling of end-stage dilated cardiomyopathy using a human cardiovascular-based cDNA microarray. Am J Pathol 2002, 160:2035-2043.
26. Lygren B., Carlson C.R., Santamaria K., Lissandron V., McSorley T., Litzenberg J., et al. AKAP complex regulates Ca2+ re-uptake into heart sarcoplasmic reticulum. EMBO Rep 2007, 8:1061-1067.
27. Gray P.C., Johnson B.D., Westenbroek R.E., Hays L.G., Yates J.R., Scheuer T., et al. Primary structure and function of an A kinase anchoring protein associated with calcium channels. Neuron 1998, 20:1017-1026.
28. Kapiloff M.S., Jackson N., Airhart N. mAKAP and the ryanodine receptor are part of a multi-component signaling complex on the cardiomyocyte nuclear envelope. J Cell Sci 2001, 114:3167-3176.
29. Lin F., Wang H., Malbon C.C. Gravin-mediated formation of signaling complexes in beta 2-adrenergic receptor desensitization and resensitization. J Biol Chem 2000, 275:19025-19034.
30. Nichols C.B., Rossow C.F., Navedo M.F., Westenbroek R.E., Catterall W.A., Santana L.F., et al. Sympathetic stimulation of adult cardiomyocytes requires association of AKAP5 with a subpopulation of L-Type calcium channels. Circ Res 2010, 107:747-756.
31. Fentzke R.C., Korcarz C.E., Lang R.M., Lin H., Leiden J.M. Dilated cardiomyopathy in transgenic mice expressing a dominant-negative CREB transcription factor in the heart. J Clin Invest 1998, 101:2415-2426.
32. Carnegie G.K., Soughayer J., Smith F.D., Pedroja B.S., Zhang F., Diviani D., et al. AKAP-Lbc mobilizes a cardiac hypertrophy signaling pathway. Mol Cell 2008, 32:169-179.
33. Dodge-Kafka K.L., Soughayer J., Pare G.C., Carlisle Michel J.J., Langeberg L.K., Kapiloff M.S., et al. The protein kinase A anchoring protein mAKAP coordinates two integrated cAMP effector pathways. Nature 2005, 437:574-578.
34. Kammerer S., Burns-Hamuro L.L., Ma Y., Hamon S.C., Canaves J.M., Shi M.M., et al. Amino acid variant in the kinase binding domain of dual-specific A kinase-anchoring protein 2: a disease susceptibility polymorphism. Proc Natl Acad Sci USA 2003, 100:4066-4071.
35. Saucerman J.J., Healy S.N., Belik M.E., Puglisi J.L., McCulloch A.D. Proarrhythmic consequences of a KCNQ1 AKAP-binding domain mutation: computational models of whole cells and heterogeneous tissue. Circ Res 2004, 95:1216-1224.
36. Zaccolo M., Movsesian M.A. cAMP and cGMP signaling cross-talk: role of phosphodiesterases and implications for cardiac pathophysiology. Circ Res 2007, 100:1569-1578.
37. Schroder F., Klein G., Fiedler B., Bastein M., Schnasse N., Hillmer A., et al. Single L-type Ca(2+) channel regulation by cGMP-dependent protein kinase type I in adult cardiomyocytes from PKG I transgenic mice. Cardiovasc Res 2003, 60:268-277.
38. Martinez S.E., Wu A.Y., Glavas N.A., Tang X.B., Turley S., Hol W.G., et al. The two GAF domains in phosphodiesterase 2A have distinct roles in dimerization and in cGMP binding. Proc Natl Acad Sci USA 2002, 99:13260-13265.
39. Mongillo M., Tocchetti C.G., Terrin A., Lissandron V., Cheung Y.F., Dostmann W.R., et al. Compartmentalized phosphodiesterase-2 activity blunts beta-adrenergic cardiac inotropy via an NO/cGMP-dependent pathway. Circ Res 2006, 98:226-234.
40. Mauban J.R., O'Donnell M., Warrier S., Manni S., Bond M. AKAP-scaffolding proteins and regulation of cardiac physiology. Physiology (Bethesda) 2009, 24:78-87.
41. Scholten A., Aye T.T., Heck A.J. A multi-angular mass spectrometric view at cyclic nucleotide dependent protein kinases: in vivo characterization and structure/function relationships. Mass Spectrom Rev 2008, 27:331-353.
42. MacLennan D.H., Kranias E.G. Phospholamban: a crucial regulator of cardiac contractility. Nat Rev Mol Cell Biol 2003, 4:566-577.
43. Chaturvedi D., Cohen M.S., Taunton J., Patel T.B. The PKARIalpha subunit of protein kinase A modulates the activation of p90RSK1 and its function. J Biol Chem 2009, 284:23670-23681.
44. Tagawa H., Koide M., Sato H., Zile M.R., Carabello B.A., Cooper GT Cytoskeletal role in the transition from compensated to decompensated hypertrophy during adult canine left ventricular pressure overloading. Circ Res 1998, 82:751-761.
45. Leterrier J.F., Kurachi M., Tashiro T., Janmey P.A. MAP2-mediated in vitro interactions of brain microtubules and their modulation by cAMP. Eur Biophys J 2009, 38:381-393.
46. Nath K., Shay J.W., Bollon A.P. Relationship between dibutyryl cyclic AMP and microtubule organization in contracting heart muscle cells. Proc Natl Acad Sci USA 1978, 75:319-323.
47. Marx S.O., Kurokawa J., Reiken S., Motoike H., D'Armiento J., Marks A.R., et al. Requirement of a macromolecular signaling complex for beta adrenergic receptor modulation of the KCNQ1-KCNE1 potassium channel. Science 2002, 295:496-499.
48. Terrenoire C., Houslay M.D., Baillie G.S., Kass R.S. The cardiac IKs potassium channel macromolecular complex includes the phosphodiesterase PDE4D3. J Biol Chem 2009, 284:9140-9146.
49. Chen L., Marquardt M.L., Tester D.J., Sampson K.J., Ackerman M.J., Kass R.S. Mutation of an A-kinase-anchoring protein causes long-QT syndrome. Proc Natl Acad Sci USA 2007, 104:20990-20995.
50. Boulaksil M., Winckels S.K., Engelen M.A., Stein M., van Veen T.A., Jansen J.A., et al. Heterogeneous Connexin43 distribution in heart failure is associated with dispersed conduction and enhanced susceptibility to ventricular arrhythmias. Eur J Heart Fail 2010, 12:913-921.
51. Sfichi-Duke L., Garcia-Cazarin M.L., Sumandea C.A., Sievert G.A., Balke C.W., Zhan D.Y., et al. Cardiomyopathy-causing deletion K210 in cardiac troponin T alters phosphorylation propensity of sarcomeric proteins. J Mol Cell Cardiol 2010, 48:934-942.